Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients

Inski Yu, Richard N. Greenberg, Timothy N. Crawford, Alice C. Thornton, Thein Myint

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The duration of macrocytosis after stopping zidovudine (ZDV) is unknown. Among 104 HIV-infected patients treated with ZDV for more than 1 year, 84 patients had macrocytosis at ZDV discontinuation. The median mean corpuscular volume (MCV) was 114.6 fL (range 100-128 fL). Patients were divided into 2 groups: those who did (resolved macrocytosis, n = 36) and did not (persistent macrocytosis, n = 48) normalize MCV at 3 to 6 months after ZDV discontinuation. Alcohol use (P =.02), smoking (P =.03), and lower (but within normal range) folic acid levels (P =.05) were related to the persistence of macrocytosis. A persistence of macrocytosis was observed in 57% at 3 to 6 months, 38% at 1 year and 37% at 2 years after ZDV therapy had stopped. Duration of ZDV therapy did not have an effect on the persistence of macrocytosis (P =.73). The median time for the MCV to normalize after stopping ZDV was 12.5 months.

Original languageEnglish
Pages (from-to)512-515
Number of pages4
JournalJournal of the International Association of Providers of AIDS Care
Volume16
Issue number5
DOIs
StatePublished - Sep 1 2017

Bibliographical note

Publisher Copyright:
© SAGE Publications.

Keywords

  • HIV
  • discontinuation
  • macrocytosis
  • persistence
  • zidovudine

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients'. Together they form a unique fingerprint.

Cite this